Open AccessDynein axonemal heavy chain 9 M4374I variation may have an effect on imatinib mesylate resistance in CML
Author(s) -
Mahmut Yildirim,
Levent Şi̇mşek,
Ayşe Gül Zamanı,
Özcan Çeneli̇,
Si̇nan Demi̇rci̇oğlu
Publication year - 2022
Publication title -
medicine international
Language(s) - English
Resource type - Journals
eISSN - 2754-3242
pISSN - 2754-1304
DOI - 10.3892/mi.2022.29
Subject(s) - imatinib , imatinib mesylate , abl , tyrosine kinase , biology , chronic myelogenous leukemia , protein kinase domain , tyrosine kinase inhibitor , cancer research , leukemia , genetics , gene , myeloid leukemia , signal transduction , cancer , mutant